Literature Collection

9301

Suicide prevention: Evaluation of a pilot intervention in a primary care context

Type: Journal Article

Authors: Kylie King, Bridget Bassilios, Lennart Reifels, Justine Fletcher, Maria Ftanou, Grant Blashki, Philip Burgess, Jane Pirkis

Year: 2013

Topic(s):

Reference Links:

Export Citation: RIS

View details

9302

Suicide risk assessment and safety planning in integrated primary care settings: Recommendations for behavioral health consultants

Type: Journal Article

Authors: Aubrey R. Dueweke, Ana J. Bridges

Year: 2022

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

9303

Suicide: A Silent Contributor to Opioid-Overdose Deaths

Type: Journal Article

Authors: M. A. Oquendo, N. D. Volkow

Year: 2018

Abstract: As the toll of opioid-overdose deaths in the United States rises, we face an urgent need for prevention. But preventing such deaths will require a better understanding of the diverse trajectories by which overdoses occur, including the distinction between intentional (suicide) and unintentional (accidental) deaths, be they in patients with chronic pain who overdose on their opioid analgesics or in those with a primary opioid use disorder (OUD). Interventions to prevent overdose deaths in suicidal people will differ from interventions targeted at accidental overdoses. Yet most strategies for reducing opioid-overdose deaths do not include screening for suicide risk, nor do they address the need to tailor interventions for suicidal persons. Moreover, the inaccuracy of available data on the proportion of suicides among opioid-overdose deaths � which are frequently classified as �undetermined� if there is no documented history of depression or a suicide note � hinders deployment of appropriate prevention services.

Topic(s):

Reference Links:

Export Citation: RIS

View details

9304

Summary of the HIPAA Privacy Rule

Type: Web Resource

Authors: U.S. Department of Health and Human Services Office for Civil Rights

Year: 2003

Topic(s):

,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

PDF (372.1 KB)

Reference Links: PDF (372.1 KB)

Export Citation: RIS

View details

9305

Summary of the National Demonstration Project and recommendations for the patient-centered medical home

Type: Journal Article

Authors: B. F. Crabtree, P. A. Nutting, W. L. Miller, K. C. Stange, E. E. Stewart, C. R. Jaen

Year: 2010

Publication Place: United States

Abstract: This article summarizes findings from the National Demonstration Project (NDP) and makes recommendations for policy makers and those implementing patient-centered medical homes (PCMHs) based on these findings and an understanding of diverse efforts to transform primary care. The NDP was launched in June 2006 as the first national test of a particular PCMH model in a diverse sample of 36 family practices, randomized to facilitated or self-directed groups. An independent evaluation team used a multimethod evaluation strategy, analyzing data from direct observation, depth interviews, e-mail streams, medical record audits, and patient and clinical staff surveys. Peer-reviewed manuscripts from the NDP provide answers to 4 key questions: (1) Can the NDP model be built? (2) What does it take to build the NDP model? (3) Does the NDP model make a difference in quality of care? and (4) Can the NDP model be widely disseminated? We find that although it is feasible to transform independent practices into the NDP conceptualization of a PCMH, this transformation requires tremendous effort and motivation, and benefits from external support. Most practices will need additional resources for this magnitude of transformation. Recommendations focus on the need for the PCMH model to continue to evolve, for delivery system reform, and for sufficient resources for implementing personal and practice development plans. In the meantime, we find that much can be done before larger health system reform.

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

9306

Summit: Procedures for Medication-Assisted Treatment of Alcohol or Opioid Dependence in Primary Care

Type: Report

Authors: Keith G. Heinzerling, Allison J. Ober, Karen Lamp, David De Vries, Katherine E. Watkins

Year: 2016

Publication Place: Santa Monica, CA

Topic(s):

,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

PDF (3.1 MB)

Reference Links: PDF (3.1 MB)

Export Citation: RIS

View details

9307

Supervised dosing with a long-acting opioid medication in the management of opioid dependence

Type: Journal Article

Authors: R. Saulle, S. Vecchi, L. Gowing

Year: 2017

Publication Place: England

Abstract: BACKGROUND: Opioid dependence (OD) is an increasing clinical and public health problem worldwide. International guidelines recommend opioid substitution treatment (OST), such as methadone and buprenorphine, as first-line medication treatment for OD. A negative aspect of OST is that the medication used can be diverted both through sale on the black market, and the unsanctioned use of medications. Daily supervised administration of medications used in OST has the advantage of reducing the risk of diversion, and may promote therapeutic engagement, potentially enhancing the psychosocial aspect of OST, but costs more and is more restrictive on the client than dispensing for off-site consumption. OBJECTIVES: The objective of this systematic review is to compare the effectiveness of OST with supervised dosing relative to dispensing of medication for off-site consumption. SEARCH METHODS: We searched in Cochrane Drugs and Alcohol Group Specialised Register and Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, CINAHL, Web of Science from inception up to April 2016. Ongoing and unpublished studies were searched via ClinicalTrials.gov (www.clinicaltrials.gov) and World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (http://www.who.int/ictrp/en/).All searches included non-English language literature. We handsearched references on topic-related systematic reviews. SELECTION CRITERIA: Randomised controlled trials (RCTs), controlled clinical trials (CCTs), and prospective controlled cohort studies, involving people who are receiving OST (methadone, buprenorphine) and comparing supervised dosing with dispensing of medication to be consumed away from the dispensing point, usually without supervision. DATA COLLECTION AND ANALYSIS: We used the standard methodological procedures expected by Cochrane. MAIN RESULTS: Six studies (four RCTs and two prospective observational cohort studies), involving 7999 participants comparing supervised OST treatment with unsupervised treatment, met the inclusion criteria. The risk of bias was generally moderate across trials, but the results reported on outcomes that we planned to consider were limited. Overall, we judged the quality of the evidence from very low to low for all the outcomes.We found no difference in retention at any duration with supervised compared to unsupervised dosing (RR 0.99, 95% CI 0.88 to 1.12, 716 participants, four trials, low-quality evidence) or in retention in the shortest follow-up period, three months (RR 0.94; 95% CI 0.84 to 1.05; 472 participants, three trials, low-quality evidence). Additional data at 12 months from one observational study found no difference in retention between groups (RR 0.94, 95% CI 0.77 to 1.14; n = 300).There was no difference in abstinence at the end of treatment (self-reported drug use) (67% versus 60%, P = 0.33, 293 participants, one trial, very low-quality evidence); and in diversion of medication (5% versus 2%, 293 participants, one trial, very low-quality evidence).Regarding our secondary outcomes, we did not found a difference in the incidence of adverse effects in the supervised compared to unsupervised control group (RR 0.63; 96% CI 0.10 to 3.86; 363 participants, two trials, very low-quality evidence). Data on severity of dependence were very limited (244 participants, one trial) and showed no difference between the two approaches. Data on deaths were reported in two studies. One trial reported two deaths in the supervised group (low-quality evidence), while in the cohort study all-cause mortality was found lower in regular supervision group (crude mortality rate 0.60 versus 0.81 per 100 person-years), although after adjustment insufficient evidence existed to suggest that regular supervision was protective (mortality rate ratio = 1.23, 95% CI = 0.67 to 2.27).No studies reported pain symptoms, drug craving, aberrant opioid-related behaviours, days of unsanctioned opioid use and overdose. AUTHORS' CONCLUSIONS: Take-home medication strategies are attractive to treatment services due to lower costs, and place less restrictions on clients, but it is unknown whether they may be associated with increased risk of diversion and unsanctioned use of medication. There is uncertainty about the effects of supervised dosing compared with unsupervised medication due to the low and very low quality of the evidence for the primary outcomes of interest for this review. Data on defined secondary outcomes were similarly limited. More research comparing supervised and take-home medication strategies is needed to support decisions on the relative effectiveness of these strategies. The trials should be designed and conducted with high quality and over a longer follow-up period to support comparison of strategies at different stages of treatment. In particular, there is a need for studies assessing in more detail the risk of diversion and safety outcomes of using supervised OST to manage opioid dependence.

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

9308

Supervised inhalation sites: Preventing overdose and reducing health inequities among people who use drugs

Type: Journal Article

Authors: Alison Lu, Claire Kim, Joseph G. Rosen, Erin Thompson, Jessica Tardif, Ralph Welwean, Ju Nyeong Park

Year: 2023

Topic(s):

Reference Links:

Export Citation: RIS

View details

9309

Supervised Tablet Injectable Opioid Agonist Therapy (TiOAT): A Strategy to Address Safer Supply for Individuals With an Opioid Use Disorder?

Type: Journal Article

Authors: Jian Weng, Nadia Fairbairn, Christy Sutherland, Cheyenne Johnson, Seonaid Nolan

Year: 2022

Topic(s):

Access Resource

Reference Links: Access Resource

Export Citation: RIS

View details

9310

Supervision in Primary Care

Type: Report

Authors: S. Bailey

Year: 2015

Topic(s):

,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Access Resource

Reference Links: Access Resource

Export Citation: RIS

View details

9311

Supplemental Appendix S11: Primary Care Referral and Feedback Form

Type: Journal Article

Year: 2010

Publication Place: Elk Grove Village, IL

Topic(s):

Reference Links:

Export Citation: RIS

View details

9312

Supply and Distribution of the Behavioral Health Workforce in Rural America. Data Brief #160

Type: Report

Authors: E. H. Larson, D. G. Patterson, L. A. Garberson, C. H. A. Andrilla

Year: 2016

Publication Place: Seattle, WA

Topic(s):

, ,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

PDF (2980 KB)

Reference Links: PDF (2980 KB)

Export Citation: RIS

View details

9313

Support for Safe Consumption Sites Among Peer Recovery Coaches

Type: Journal Article

Authors: E. Pasman, S. Brown, E. Agius, S. M. Resko

Year: 2024

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

9314

Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics

Type: Journal Article

Authors: A. Forray, A. Mele, N. Byatt, Londono Tobon, K. Gilstad-Hayden, K. Hunkle, S. Hong, H. Lipkind, D. A. Fiellin, K. Callaghan, K. A. Yonkers

Year: 2022

Abstract:

INTRODUCTION: The prevalence of opioid use disorder (OUD) in pregnancy increased nearly five-fold over the past decade. Despite this, obstetric providers are less likely to treat pregnant women with medication for OUD than non-obstetric providers (75% vs 91%). A major reason is many obstetricians feel unprepared to prescribe medication for opioid use disorder (MOUD). Education and support may increase prescribing and overall comfort in delivering care for pregnant women with OUD, but optimal models of education and support are yet to be determined. METHODS AND ANALYSIS: We describe the rationale and conduct of a matched-pair cluster randomized clinical trial to compare the effectiveness of two models of support for reproductive health clinicians to provide care for pregnant and postpartum women with OUD. The primary outcomes of this trial are patient treatment engagement and retention in OUD treatment. This study compares two support models: 1) a collaborative care approach, based upon the Massachusetts Office-Based-Opioid Treatment Model, that provides practice-level training and support to providers and patients through the use of care managers, versus 2) a telesupport approach based on the Project Extension for Community Healthcare Outcomes, a remote education model that provides mentorship, guided practice, and participation in a learning community, via video conferencing. DISCUSSION: This clustered randomized clinical trial aims to test the effectiveness of two approaches to support practitioners who care for pregnant women with an OUD. The results of this trial will help determine the best model to improve the capacity of obstetrical providers to deliver treatment for OUD in prenatal clinics. TRIAL REGISTRATION: Clinicaltrials.gov trial registration number: NCT0424039.

Topic(s):

, ,

Reference Links:

Export Citation: RIS

View details

9315

Supporting families through the application of a rural pediatric integrated care model

Type: Journal Article

Authors: Amy D. Habeger, Victoria M. Venable

Year: 2018

Publication Place: Philadelphia, Pennsylvania

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

9316

Supporting mental health in South African HIV-affected communities: primary health care professionals' understandings and responses

Type: Journal Article

Authors: R. A. Burgess

Year: 2014

Topic(s):

Reference Links:

Export Citation: RIS

View details

9317

Supporting nurses to provide primary mental health care

Type: Journal Article

Authors: E. McKinlay, J. Davison

Year: 2011

Publication Place: New Zealand

Topic(s):

Reference Links:

Export Citation: RIS

View details

9318

Supporting Older Adults Unmet Needs, Social Determinants of Health, and Depression Care Within the Strained Landscape of Primary Care: The Care Partners Initiative

Type: Journal Article

Authors: K. Fortuna, D. E. Jimenez, J. A. Sirey

Year: 2024

Topic(s):

Reference Links:

Export Citation: RIS

View details

9319

Supporting patient engagement in the patient-centered medical home

Type: Report

Authors: J. Gruman, D. Jeffress, S. Edgman-Levitan, L. Simmons, W. '. Kormos

Year: 2009

Topic(s):

,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

PDF (62.95 KB)

Reference Links: PDF (62.95 KB)

Export Citation: RIS

View details

9320

Supporting People Experiencing Homelessness in Smoking Cessation

Type: Government Report

Authors: National Health Care for the Homeless Council

Year: 2024

Publication Place: Nashville, TN

Topic(s):

, ,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

PDF (1580 KB)

Reference Links: PDF (1580 KB)

Export Citation: RIS

View details